Literature DB >> 26864308

IL-33 mediates reactive eosinophilopoiesis in response to airborne allergen exposure.

E L Anderson1, T Kobayashi2, K Iijima2, K R Bartemes1, C-C Chen1, H Kita1,2.   

Abstract

BACKGROUND: Exposure to aeroallergens induces eosinophilic airway inflammation in patients with asthma and allergic airway diseases. The circulating number of eosinophils in peripheral blood is relatively small, leading us to hypothesize that bone marrow needs to be engaged quickly to meet the demands of the tissues.
METHODS: To investigate the communication between the lungs and bone marrow, we used acute allergen exposure and airway inflammation models in mice. Gene-deficient mice and cytokine reporter mice as well as in vitro cell culture models were used to dissect the mechanisms.
RESULTS: Naïve BALB/c mice produced increased numbers of eosinophil precursors and mature eosinophils in the bone marrow when their airways were exposed to a common fungal allergen, Alternaria alternata. Expression of IL-5 and IL-33 increased rapidly in the lungs, but not in the bone marrow. Sera from allergen-exposed mice promoted eosinophilopoiesis in bone marrow cells from naïve mice, which was blocked by anti-IL-5 antibody. Mice deficient in the IL-33 receptor ST2 (i.e., Il1rl1(-/-) mice) were unable to increase their serum levels of IL-5 and allergen-induced eosinophilopoiesis in the bone marrow after allergen exposure. Finally, group 2 innate lymphoid cells (ILC2s) in the lungs showed robust expression of IL-5 after Alternaria exposure.
CONCLUSIONS: These finding suggests that lung IL-33, through innate activation of ILC2s and their production of IL-5, plays a key role in promoting acute reactive eosinophilopoiesis in the bone marrow when naïve animals are exposed to airborne allergens. Therefore, bone marrow eosinophilopoiesis may be affected by atmospheric environmental conditions.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IL-33; IL-5; eosinophilopoiesis; eosinophils

Mesh:

Substances:

Year:  2016        PMID: 26864308      PMCID: PMC5107318          DOI: 10.1111/all.12861

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  44 in total

1.  Dynamic role of epithelium-derived cytokines in asthma.

Authors:  Kathleen R Bartemes; Hirohito Kita
Journal:  Clin Immunol       Date:  2012-03-20       Impact factor: 3.969

Review 2.  Epithelium: at the interface of innate and adaptive immune responses.

Authors:  Robert P Schleimer; Atsushi Kato; Robert Kern; Douglas Kuperman; Pedro C Avila
Journal:  J Allergy Clin Immunol       Date:  2007-10-18       Impact factor: 10.793

Review 3.  The eosinophil.

Authors:  Marc E Rothenberg; Simon P Hogan
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

Review 4.  Asthma phenotypes: the evolution from clinical to molecular approaches.

Authors:  Sally E Wenzel
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

5.  Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice.

Authors:  M D Inman; R Ellis; J Wattie; J A Denburg; P M O'Byrne
Journal:  Am J Respir Cell Mol Biol       Date:  1999-10       Impact factor: 6.914

Review 6.  The link between fungi and severe asthma: a summary of the evidence.

Authors:  D W Denning; B R O'Driscoll; C M Hogaboam; P Bowyer; R M Niven
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

Review 7.  A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma.

Authors:  William W Busse; Johannes Ring; Johannes Huss-Marp; Jean-Emmanuel Kahn
Journal:  J Allergy Clin Immunol       Date:  2010-04       Impact factor: 10.793

8.  Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33.

Authors:  Christina A Christianson; Nicholas P Goplen; Iram Zafar; Chaoyu Irvin; James T Good; Donald R Rollins; Balachandra Gorentla; Weimin Liu; Magdalena M Gorska; HongWei Chu; Richard J Martin; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2015-01-21       Impact factor: 10.793

9.  IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs.

Authors:  Kathleen R Bartemes; Koji Iijima; Takao Kobayashi; Gail M Kephart; Andrew N McKenzie; Hirohito Kita
Journal:  J Immunol       Date:  2011-12-23       Impact factor: 5.422

10.  Type 2 innate lymphoid cells control eosinophil homeostasis.

Authors:  Jesse C Nussbaum; Steven J Van Dyken; Jakob von Moltke; Laurence E Cheng; Alexander Mohapatra; Ari B Molofsky; Emily E Thornton; Matthew F Krummel; Ajay Chawla; Hong-Erh Liang; Richard M Locksley
Journal:  Nature       Date:  2013-09-15       Impact factor: 49.962

View more
  21 in total

Review 1.  Advances in environmental and occupational disorders in 2016.

Authors:  William J Sheehan; Jonathan M Gaffin; David B Peden; Robert K Bush; Wanda Phipatanakul
Journal:  J Allergy Clin Immunol       Date:  2017-12       Impact factor: 10.793

2.  Endogenous prostaglandin E2 amplifies IL-33 production by macrophages through an E prostanoid (EP)2/EP4-cAMP-EPAC-dependent pathway.

Authors:  Sachin K Samuchiwal; Barbara Balestrieri; Hannah Raff; Joshua A Boyce
Journal:  J Biol Chem       Date:  2017-03-24       Impact factor: 5.157

Review 3.  Eosinophils: The unsung heroes in cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Valeria Lucarini; Giancarlo Marone; Fabrizio Mattei; Gianni Marone; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

4.  Streptococcus pneumoniae aminopeptidase N regulates dendritic cells that attenuates type-2 airway inflammation in murine allergic asthma.

Authors:  Guangying Wu; Xuemei Zhang; Xu Chen; Jian Wang; Jing Yang; Ling Wang; Si Sun; Yuhong Qi; Hong Wang; Yibing Yin; Wenchun Xu
Journal:  Br J Pharmacol       Date:  2020-09-20       Impact factor: 8.739

5.  Bone marrow type 2 innate lymphoid cells: a local source of interleukin-5 in interleukin-33-driven eosinophilia.

Authors:  Kristina Johansson; Carina Malmhäll; Patricia Ramos-Ramírez; Madeleine Rådinger
Journal:  Immunology       Date:  2017-10-19       Impact factor: 7.397

6.  Eosinophils and eosinophil-associated diseases: An update.

Authors:  Jeremy A O'Sullivan; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2017-10-16       Impact factor: 10.793

Review 7.  Type two innate lymphoid cells: the Janus cells in health and disease.

Authors:  Hadi Maazi; Omid Akbari
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

8.  Eosinophil persistence in vivo and sustained viability ex vivo in response to respiratory challenge with fungal allergens.

Authors:  W E Geslewitz; C M Percopo; H F Rosenberg
Journal:  Clin Exp Allergy       Date:  2017-11-22       Impact factor: 5.018

9.  The PGI2 Analog Cicaprost Inhibits IL-33-Induced Th2 Responses, IL-2 Production, and CD25 Expression in Mouse CD4+ T Cells.

Authors:  Weisong Zhou; Jian Zhang; Shinji Toki; Kasia Goleniewska; Marc O Johnson; Melissa H Bloodworth; Dawn C Newcomb; R Stokes Peebles
Journal:  J Immunol       Date:  2018-08-20       Impact factor: 5.422

10.  IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils.

Authors:  Valeria Lucarini; Giovanna Ziccheddu; Iole Macchia; Valentina La Sorsa; Francesca Peschiaroli; Carla Buccione; Antonella Sistigu; Massimo Sanchez; Sara Andreone; Maria Teresa D'Urso; Massimo Spada; Daniele Macchia; Claudia Afferni; Fabrizio Mattei; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-04-20       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.